Protein drug design

Proteinläkemedels-design

We develop protein drugs and transporters through rational in silico design to understand the mechanism behind diseases and how we can treat these.

About us

Immunotherapy is one of the fastest growing fields within drug development. The antibodies that are used and cannot pass cell membranes or the blood-brain barrier (BBB). Hence, they can only reach easily accessible targets unless they are modified. The goal with our research is to open up possibilities to reach new goals. We design and evaluate multispecific antibodies, where some parts bind to the things one wants to modify or detect in a disease and other parts acts as transporters to bring the antibody to its target.

An antibody with blood brain barrier transporters

An antibody with blood brain barrier transporters. How the transporters are linked to the antibody is important for its function.

In addition to reserach we have also started the Master's Programme in Biopharmaceuticals. Greta Hultqvist is the study director and most people in the group is involved in the teaching on the different courses.

Group members

Research leader: Greta Hultqvist
Group members: Inga Petersen, Andrés de la Rosa, Ana Godec, Jamie Morrison, Nicole Metzendorf, Prune Leroy

FOLLOW UPPSALA UNIVERSITY ON

facebook
instagram
twitter
youtube
linkedin